Chronic obstructive pulmonary disease (COPD) is a common condition that affects up to 10% of individuals aged 40 years or older. It’s also the third-leading cause of death in the United States, killing more than 120,000 individuals each year. Treating COPD can be complicated with all of the rescue inhalers and maintenance medications out there. Here’s what you need to know about Spiriva, the once-daily prescription drug for COPD. See More
Spiriva (tiotropium) is used to treat chronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis. Spiriva is more popular than other anticholinergics. There are currently no generic alternatives to Spiriva.
Check our savings tips for co-pay cards, assistance programs, and other ways to reduce your cost. Spiriva is covered by most Medicare and insurance plans.
Tiotropium Latest News
Get the latest updates on this drug from the GoodRx medical team
Have you ever gone to the pharmacy only to realize that you’re on the hook for a high copay or your insurance just won’t cover your medication at all. You’re not alone. Luckily, many drug manufacturers offer savings through copay cards, also known as manufacturer coupons. These programs are typically for brand-name drugs, and can lower the price of your medication to as little as $0.
GoodRx currently has information on over 680 active copay cards for hundreds of prescription medications. See More
Stiolto Respimat (tiotropium bromide/olodaterol) has just been approved by the FDA for the maintenance treatment of COPD, and should be available in pharmacies soon.
Spiriva (tiotropium bromide) is now available as a Respimat inhaler in addition to the original Handihaler formulation.
Although this may come as a surprise—why would we need a new version of Spiriva?—it is not the first time we have seen something like this from the pharmaceutical manufacturer Boehringer Ingelheim. For example, before the original Combivent (ipratropium bromide and albuterol) inhaler was discontinued, it was also available in two formulations: the new Respimat and the original aerosol inhaler. See More
Suffering from chronic obstructive lung disease (COPD) stinks, and so does paying a ton of money for your COPD inhalers. Spiriva (tiotropium) is probably your most expensive inhaler and you will wonder if it’s worth the cost. Insurance companies don’t like to pay for it and there is no generic option that is similar.
Spiriva is a long-acting anti-cholinergic inhaler used once a day for COPD. Spiriva has been shown to work better than Atrovent (ipratropium), which has been the much cheaper mainstay of COPD treatment. See More
A new long acting inhaler has been approved for the treatment of Chronic Obstructive Pulmonary Disease (COPD). The new inhaler, Tudorza Pressair, is due to come out this year and compete with Spiriva. The active ingredient in this new inhaler is aclidinium, a long-acting anticholinergic agent that was approved by the FDA for long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD). See More